Sino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026

Bulletin Express

Aug 19

Sino Biopharmaceutical Limited (abbreviated as “Sino Biopharm”) has declared an ordinary interim dividend of HKD 0.07 per share for the six months ended 30 June 2026. The payout relates to the financial year ending 31 December 2026.

Shareholders recorded on 4 September 2026 will be entitled to the distribution. Key dates are as follows: the stock trades ex-dividend on 1 September 2026; transfer documents must be lodged by 16:30 on 2 September 2026; the register of members will be closed from 3 to 4 September 2026. Dividend payments are scheduled for 24 September 2026, with settlement in Hong Kong dollars at an exchange rate of HKD 1:HKD 1. No shareholder approval is required, and no withholding tax information was disclosed.

The company’s board comprises five executive directors—Ms. Tse Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse Eric S Y and Mr. Tse Hsin—and six independent non-executive directors: Mr. Lu Zhengfei, Ms. Lu Hong, Mr. Zhang Lu Fu, Dr. Li Kwok Tung Donald, Dr. Chen Lieping and Dr. Lu Bai.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1109345663"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109345663\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109345663?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109345663","market":"hk","top_or_hot":-1,"title":"Sino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026","media":"Bulletin Express","content":"<p>Sino Biopharmaceutical Limited (abbreviated as “Sino Biopharm”) has declared an ordinary interim dividend of HKD 0.07 per share for the six months ended 30 June 2026. The payout relates to the financial year ending 31 December 2026.</p>\n<p>Shareholders recorded on 4 September 2026 will be entitled to the distribution. Key dates are as follows: the stock trades ex-dividend on 1 September 2026; transfer documents must be lodged by 16:30 on 2 September 2026; the register of members will be closed from 3 to 4 September 2026. Dividend payments are scheduled for 24 September 2026, with settlement in Hong Kong dollars at an exchange rate of HKD 1:HKD 1. No shareholder approval is required, and no withholding tax information was disclosed.</p>\n<p>The company’s board comprises five executive directors—Ms. Tse Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse Eric S Y and Mr. Tse Hsin—and six independent non-executive directors: Mr. Lu Zhengfei, Ms. Lu Hong, Mr. Zhang Lu Fu, Dr. Li Kwok Tung Donald, Dr. Chen Lieping and Dr. Lu Bai.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-19 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sino Biopharmaceutical Limited (abbreviated as “Sino Biopharm”) has declared an ordinary interim dividend of HKD 0.07 per share for the six months ended 30 June 2026. The payout relates to the financial year ending 31 December 2026.</p>\n<p>Shareholders recorded on 4 September 2026 will be entitled to the distribution. Key dates are as follows: the stock trades ex-dividend on 1 September 2026; transfer documents must be lodged by 16:30 on 2 September 2026; the register of members will be closed from 3 to 4 September 2026. Dividend payments are scheduled for 24 September 2026, with settlement in Hong Kong dollars at an exchange rate of HKD 1:HKD 1. No shareholder approval is required, and no withholding tax information was disclosed.</p>\n<p>The company’s board comprises five executive directors—Ms. Tse Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse Eric S Y and Mr. Tse Hsin—and six independent non-executive directors: Mr. Lu Zhengfei, Ms. Lu Hong, Mr. Zhang Lu Fu, Dr. Li Kwok Tung Donald, Dr. Chen Lieping and Dr. Lu Bai.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1109345663","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109345663","pubTimestamp":1787129216,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sino Biopharmaceutical Limited (abbreviated as “Sino Biopharm”) has declared an ordinary interim dividend of HKD 0.07 per share for the six months ended 30 June 2026. The payout relates to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"中国生物制药派发0.07港元中期股息，将于2026年9月24日派付","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"Sino Biopharmaceutical Limited (abbreviated as “Sino Biopharm”) has declared an ordinary interim dividend of HKD 0.07 per share for the six months ended 30 June 2026. The payout relates to the financial year ending 31 December 2026.\nShareholders recorded on 4 September 2026 will be entitled to the distribution. Key dates are as follows: the stock trades ex-dividend on 1 September 2026; transfer documents must be lodged by 16:30 on 2 September 2026; the register of members will be closed from 3 to 4 September 2026. Dividend payments are scheduled for 24 September 2026, with settlement in Hong Kong dollars at an exchange rate of HKD 1:HKD 1. No shareholder approval is required, and no withholding tax information was disclosed.\nThe company’s board comprises five executive directors—Ms. Tse Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse Eric S Y and Mr. Tse Hsin—and six independent non-executive directors: Mr. Lu Zhengfei, Ms. Lu Hong, Mr. Zhang Lu Fu, Dr. Li Kwok Tung Donald, Dr. Chen Lieping and Dr. Lu Bai.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}